These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 12872001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.
    Morelli F, Romeo M, Barzago MM, Bolis M, Mattioni D, Rossi G, Tagliavini F, Bastone A, Salmona M, Diomede L.
    Neurobiol Dis; 2018 Sep; 117():226-234. PubMed ID: 29936232
    [Abstract] [Full Text] [Related]

  • 3. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans.
    Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD.
    Hum Mol Genet; 2006 May 01; 15(9):1483-96. PubMed ID: 16600994
    [Abstract] [Full Text] [Related]

  • 4. Progressive neurodegeneration in C. elegans model of tauopathy.
    Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, Mitani S, Ihara Y.
    Neurobiol Dis; 2005 Nov 01; 20(2):372-83. PubMed ID: 16242642
    [Abstract] [Full Text] [Related]

  • 5. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, Martinez D, Joyce S, Trojanowski JQ, Lee VM.
    J Neurosci; 2004 May 12; 24(19):4657-67. PubMed ID: 15140937
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neurodegenerative tauopathy in the worm.
    Goedert M.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9653-5. PubMed ID: 12913116
    [No Abstract] [Full Text] [Related]

  • 11. Transgenic animal models of tauopathies.
    Lee VM, Kenyon TK, Trojanowski JQ.
    Biochim Biophys Acta; 2005 Jan 03; 1739(2-3):251-9. PubMed ID: 15615643
    [Abstract] [Full Text] [Related]

  • 12. Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation.
    Choudhary B, Mandelkow E, Mandelkow EM, Pir GJ.
    Neurobiol Dis; 2018 Sep 03; 117():189-202. PubMed ID: 29894752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C, Pir GJ, Biernat J, Koushika SP, Mandelkow E, Mandelkow EM, Schmidt E, Baumeister R.
    Hum Mol Genet; 2012 Aug 15; 21(16):3587-603. PubMed ID: 22611162
    [Abstract] [Full Text] [Related]

  • 16. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.
    Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, Lee VM, Trojanowski JQ.
    J Neurosci; 2005 Apr 06; 25(14):3539-50. PubMed ID: 15814784
    [Abstract] [Full Text] [Related]

  • 17. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG.
    J Neurosci Res; 2002 Dec 15; 70(6):734-45. PubMed ID: 12444595
    [Abstract] [Full Text] [Related]

  • 18. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
    Strang KH, Golde TE, Giasson BI.
    Lab Invest; 2019 Jul 15; 99(7):912-928. PubMed ID: 30742061
    [Abstract] [Full Text] [Related]

  • 19. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
    Lin WL, Lewis J, Yen SH, Hutton M, Dickson DW.
    J Neurocytol; 2003 Nov 15; 32(9):1091-105. PubMed ID: 15044841
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P, Sanchez-Contreras M, DeTure M, Murray ME, Rademakers R, Ross OA, Wszolek ZK, Parisi JE, Knopman DS, Petersen RC, Dickson DW.
    Neuropathol Appl Neurobiol; 2017 Apr 15; 43(3):200-214. PubMed ID: 27859539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.